BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference

INDIANAPOLIS, Sept. 7, 2011 /PRNewswire/ -- BioStorage Technologies, a global leader in scientific asset management, biomaterial storage and cold chain logistics, will host its third in a series of four Global Sample Management Benchmarking Symposia in conjunction with the 4th annual Biorepositories Conference on Sept. 19, 2011 in Boston. Featuring presentations from a diverse panel of multidisciplinary professionals and experts within the biobanking community, the symposium will examine strategies for outsourced and onsite management of biospecimen samples.  

"Biospecimen samples are critical scientific assets important to supporting today's research efforts, as well as validating future findings and advancing the development of novel therapies," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "BioStorage Technologies has been a strong supporter of the Biorepositories Conference since its inception four years ago, and holding our Global Sample Management Benchmarking in conjunction with such an impressive event was a natural fit for us."

The symposium will provide insight into trends, challenges and regulatory mandates affecting global biorepository operations, including: the emerging need for samples in specific disease areas, best practices for managing global patient consent of sample assets, onsite virtual management of sample inventories and regulatory concerns for sample management in China.

The robust speaker line up includes:

• Dr. John Bloom, President, Bloom Consulting Services, LLC and Special Government Employee to the FDA
  "Emerging Needs in the use of Biorepositories for Drug Development: Implications for Targeted Disease Therapies and Sample Asset Management"
• Dr. Karina Bienfait, Clinical Pharmacogenomics Operations Lead in Clinical Pharmacogenomics and Clinical Specimen Management, Merck & Company
  "Best Practices in the Management of Patient Informed Consent"
• Steve Sweeney, Head of Clinical Technologies, Infinity Pharmaceuticals, Inc.
  "Strategies for Improving the Onsite Management of Scientific Sample Assets"
• Suzanne M. O'Shea, Legal Counsel, Baker and Daniels LLP and former Regulatory Counsel to the U.S. Food and Drug Administration
  "Understanding How to Navigate the Regulatory Environment When Managing Samples in China"

BioStorage Technologies is also a platinum sponsor of the Biorepositories Conference, and will host several workshops at the event. Lori Ball, Chief Operating Officer, BioStorage Technologies, will co-present a workshop titled, "Manage your Biorepository to Guarantee Full Life-Cycle Specimen Quality" and Catherine Michael, Sr. Director, Comprehensive Solutions, BioStorage Technologies, will give a presentation titled, "Incorporate Quality-Control Methodologies to Identify, Control, and Eliminate Threats to Specimen Longevity and Stability."

For more information on the Global Sample Management Benchmarking Symposium, visit www.biostorage.com.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life-cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
[email protected]

SOURCE BioStorage Technologies, Inc.